{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Richmond",
      "state": "VA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "NDA050779"
        ],
        "brand_name": [
          "CEFAZOLIN SODIUM"
        ],
        "generic_name": [
          "CEFAZOLIN SODIUM"
        ],
        "manufacturer_name": [
          "B. Braun Medical Inc."
        ],
        "product_ndc": [
          "0264-3103",
          "0264-3105",
          "0264-3107"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "CEFAZOLIN SODIUM"
        ],
        "rxcui": [
          "1665050",
          "1665060",
          "2630753"
        ],
        "spl_id": [
          "fb2f076a-22b3-46e0-86c8-7678e89c9edf"
        ],
        "spl_set_id": [
          "17f8f038-c204-4dab-80d7-6f7ac41ddbec"
        ],
        "package_ndc": [
          "0264-3103-11",
          "0264-3105-11",
          "0264-3107-11"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "P380M0454Z"
        ]
      },
      "product_type": "Drugs",
      "event_id": "89646",
      "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office",
      "address_1": "9954 Maryland Drive",
      "address_2": "Deep Run Iii Ste. 4000",
      "postal_code": "23233",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "USA nationwide.",
      "recall_number": "D-1118-2022",
      "product_description": "Cefazolin for injection USP, and Dextrose Injection, USP, 2 g, 50 mL duplex container, Rx only, MFG: B. Braun Medical Inc., NDC 0264-3105-11",
      "product_quantity": "39 cases",
      "reason_for_recall": "cGMP deviations: Temperature abuse",
      "recall_initiation_date": "20220413",
      "center_classification_date": "20220609",
      "termination_date": "20231130",
      "report_date": "20220615",
      "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.",
      "more_code_info": ""
    }
  ]
}